-
Epigenetics, Epigenetics Regulation, Cancer Metabolism, Immunology, Drug Discovery, Development, and Structural Biology, with an emphasis on RNA epigenetics/epitranscriptomics (RNA modifications) and RNA-based
-
of Hope. This role offers an exciting opportunity to investigate immune checkpoint signaling within the tumor microenvironment and contribute to the development of novel anticancer therapies
-
top journals such as Journal of Hematology & Oncology (2024), Cancer Research (2024), Cell (2023), Cell Stem Cell (2023 ×2), and Nature Cell Biology (2022). The Su research program is currently
-
. The research program embraces team science drawing from i.e., implementation science, data science, geospatial, epidemiological, and machine learning approaches to better understand broad contexts including
-
: · Develop and maintain clinical and translational research trials in genitourinary cancers. · Collect, analyze, and maintain large databases pertaining to genitourinary cancers. · Draft
-
to vaccine development utilizing viral vectors to contribute to an effort in developing neoantigen expressing vaccines for clinical investigations. The position is available as part of a multi-disciplinary
-
drive our multiomics, high-throughput sequencing projects and help develop any projects based on the most advanced technologies. Your qualifications should include: Ph.D. in Biochemistry, Bioinformatics
-
laboratory focuses on developing physics-based computational methods to study protein structure, dynamics, and drug design. For more information about Dr. Vaidehi’s lab, please visit here. As a successful
-
of Hope. This role offers an exciting opportunity to investigate immune checkpoint signaling within the tumor microenvironment and contribute to the development of novel anticancer therapies
-
of adipose tissue and its link to age-related metabolic disorders and cancer. Ultimately, we aim to mitigate the pathogenesis and develop treatments for chronic metabolic diseases. We have established unique